A note to our readers

 

Since the beginning of the pandemic, back in February of 2020, I have written a newsletter every weekday evening. It has been a immensely rewarding experience and our small readership has now grown to over 30,000 subscribers.

 

We will continue to bring you important information and updates but as our clients have begun reopening and reimagining their venues, we have gotten quite busy. We are currently, working on what will be the largest outdoor concert in the US since the pandemic (you will hear about it soon), we are opening up multiple vaccination centers across New York City in underserved neighborhoods, we are working with several major endurance sporting events on their plans to hold their events this year, we have several large festivals and music events that we are working on, we still support one of the largest media/Television/Movie groups in the country and we are still running testing centers. All of us are stretched pretty thin. Its great news for us and we are excited to be part of the way out of the pandemic and the reopening of our country.

 

The downside is that I may not get to write a column every weeknight moving forward. We will see how it goes but I want to thank everyone who has written to me and contributed to our nightly newsletter. I have thoroughly enjoyed all of the feedback, both the items I agree with and the one I disagree with. Reading the different perspectives has been great.

 

Have a great weekend and get your self vaccinated quickly so we can get through this together.

 

Dr. Stu Weiss

What’s important to know on April 9, 2021

 

US Covid-19 cases and hospitalizations are increasing – particularly for younger people – while deaths are going down, the CDC director warned.

 

 

Johnson & Johnson says it’s “aware” of rare blood clotting cases but maintains there is “no clear causal relationship” with its vaccine.

 

 

The World Health Organization’s director-general says the risks from Covid-19 are much higher than AstraZeneca vaccine related risks, urging everyone to get a vaccine.

 

Johnson & Johnson will allocate 86 percent fewer doses across the United States next week than are currently being allocated, according to C.D.C. data, dealing a setback to a national vaccination campaign that has just found its footing. Around 15 million doses at a Baltimore factory had been contaminated, delaying the plant’s authorization.

 

Pfizer and BioNTech requested the F.D.A.’s authorization to use their vaccine in 12- to 15-year-olds.

 

France says those under 55 who got a first AstraZeneca shot should follow up with a different vaccine.

 

Europe’s drug regulator investigates some blood clots after Johnson & Johnson shots, but no link is clear.

 

Atlantic City casino profits dropped 80% in 2020 due to COVID

 

Japan to increase anti-virus measures in Tokyo ahead of Olympics